Outcome and Risk Factors of De Novo Autoimmune Hepatitis in Living-Donor Liver Transplantation

Abstract

This series highlights the more severe histologic outcome of de novo AIH with longer follow-up despite immunosuppressive treatment. De novo AIH may arise from alloimmunologic injury, marked by clinically obvious episodes of acute rejection.